Payden & Rygel’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,400
Closed -$184K 124
2024
Q1
$184K Hold
1,400
0.01% 122
2023
Q4
$202K Hold
1,400
0.01% 122
2023
Q3
$238K Hold
1,400
0.02% 116
2023
Q2
$312K Hold
1,400
0.02% 113
2023
Q1
$309K Hold
1,400
0.02% 108
2022
Q4
$304K Hold
1,400
0.02% 115
2022
Q3
$370K Hold
1,400
0.02% 108
2022
Q2
$293K Hold
1,400
0.02% 111
2022
Q1
$310K Hold
1,400
0.02% 107
2021
Q4
$327K Hold
1,400
0.02% 106
2021
Q3
$307K Hold
1,400
0.02% 106
2021
Q2
$236K Sell
1,400
-600
-30% -$96.8K 0.01% 113
2021
Q1
$292K Sell
2,000
-250,900
-99% -$40.3M 0.01% 103
2020
Q4
$37.3M Hold
252,900
1.91% 11
2020
Q3
$22.6M Buy
+252,900
New +$22.4M 1.34% 40

Other funds holding ALB

Payden & Rygel's ALB Position: Q2 2024 in Review

Payden & Rygel sold out of Albemarle (ALB) in Q2 2024, closing a stake of 1,400 shares — an estimated $184K sold.

Payden & Rygel first reported a position in ALB in Q3 2020 and held it in 15 quarters. The position peaked at $37.3M in Q4 2020. 843 funds tracked by Wall St. Rank hold ALB as of Q2 2024.

  • Payden & Rygel reported no remaining Albemarle position as of Q2 2024 after selling out during the quarter.
  • Payden & Rygel sold 1,400 Albemarle shares in Q2 2024, an estimated $184K.
  • Payden & Rygel first reported a position in Albemarle in Q3 2020 and held it in 15 quarters.
  • Payden & Rygel's Albemarle position peaked at $37.3M in Q4 2020.
  • 843 funds tracked by Wall St. Rank held Albemarle as of Q2 2024.

Based on Payden & Rygel's 13F filing for Q2 2024, filed 7 Oct 2024.